Novel Algorithm for HF Screening Receives FDA Breakthrough Designation

Summary: Learn more about this algorithm.
Novel Algorithm for HF Screening Receives FDA Breakthrough Designation

The algorithm, which was developed in collaboration with Mayo Clinic, uses a deep neural network to analyze 15 seconds of ECG data obtained from a digital stethoscope (Eko DUO) during a physical examination. Through this, left ventricular ejection fraction can be identified, according to the release.

"Roughly 7 million Americans have a weak heart pump and don't know it, " Paul A. Friedman, MD, chair of the department of cardiovascular medicine at Mayo Clinic in Rochester, Minnesota, told Healio. "They either have no symptoms or they may attribute their symptoms to other conditions. It's important to be aware of the condition because once ventricular dysfunction is diagnosed - once you know that you have a weak heart pump - there are a number of established, proven therapies including medications and implantable devices that lower the risk of developing symptoms and the risk of death. By identifying people with these conditions, doctors can then offer them treatment sooner. "

Read more at Cardiology Today